These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 11955341

  • 1. [Neonatal screening for congenital adrenal hyperplasia in Shanghai areas].
    Gu X, Zhou J, Ye J.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Jan; 36(1):16-8. PubMed ID: 11955341
    [Abstract] [Full Text] [Related]

  • 2. Newborn screening for congenital adrenal hyperplasia in Sapporo City: sixteen years experience.
    Mikami A, Fukushi M, Oda H, Fujita K, Fujieda K.
    Southeast Asian J Trop Med Public Health; 1999 Jan; 30 Suppl 2():100-2. PubMed ID: 11400741
    [Abstract] [Full Text] [Related]

  • 3. [Neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency. 3. An enzyme-linked immunosorbent assay for dried blood 17 alpha-hydroxyprogesterone].
    Fukushi M, Arai O, Mizushima Y, Takasugi N, Fujieda K, Matsuura N.
    Nihon Naibunpi Gakkai Zasshi; 1987 Feb 20; 63(2):113-22. PubMed ID: 3494638
    [Abstract] [Full Text] [Related]

  • 4. Neonatal screening for congenital adrenal hyperplasia in Southern Brazil: a population based study with 108,409 infants.
    Kopacek C, de Castro SM, Prado MJ, da Silva CM, Beltrão LA, Spritzer PM.
    BMC Pediatr; 2017 Jan 17; 17(1):22. PubMed ID: 28095810
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Screening for congenital adrenal hyperplasia in Hungary].
    Sólyom J.
    Orv Hetil; 1989 Sep 10; 130(37):1979-82, 1985-6. PubMed ID: 2780047
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Corrected 17-alpha-hydroxyprogesterone values adjusted by a scoring system for screening congenital adrenal hyperplasia in premature infants.
    Lee JE, Moon Y, Lee MH, Jun YH, Oh KI, Choi JW.
    Ann Clin Lab Sci; 2008 Sep 10; 38(3):235-40. PubMed ID: 18715851
    [Abstract] [Full Text] [Related]

  • 12. False positive rate in newborn screening for congenital adrenal hyperplasia (CAH)-ether extraction reveals two distinct reasons for elevated 17alpha-hydroxyprogesterone (17-OHP) values.
    Fingerhut R.
    Steroids; 2009 Aug 10; 74(8):662-5. PubMed ID: 19463687
    [Abstract] [Full Text] [Related]

  • 13. Steroid profiling for congenital adrenal hyperplasia by tandem mass spectrometry as a second-tier test reduces follow-up burdens in a tertiary care hospital: a retrospective and prospective evaluation.
    Seo JY, Park HD, Kim JW, Oh HJ, Yang JS, Chang YS, Park WS, Lee SY.
    J Perinat Med; 2014 Jan 10; 42(1):121-7. PubMed ID: 23989111
    [Abstract] [Full Text] [Related]

  • 14. No evidence of an increase in early infant mortality from congenital adrenal hyperplasia in the absence of screening.
    Hird BE, Tetlow L, Tobi S, Patel L, Clayton PE.
    Arch Dis Child; 2014 Feb 10; 99(2):158-64. PubMed ID: 24225272
    [Abstract] [Full Text] [Related]

  • 15. Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls.
    Varness TS, Allen DB, Hoffman GL.
    J Pediatr; 2005 Oct 10; 147(4):493-8. PubMed ID: 16227036
    [Abstract] [Full Text] [Related]

  • 16. Multiple positive results during a neonatal screening program: a retrospective analysis of incidence, clinical implications and outcomes.
    Zaffanello M, Maffeis C, Zamboni G.
    J Perinat Med; 2005 Oct 10; 33(3):246-51. PubMed ID: 15914349
    [Abstract] [Full Text] [Related]

  • 17. A three-year follow-up of congenital adrenal hyperplasia newborn screening.
    Pezzuti IL, Barra CB, Mantovani RM, Januário JN, Silva IN.
    J Pediatr (Rio J); 2014 Oct 10; 90(3):300-7. PubMed ID: 24560529
    [Abstract] [Full Text] [Related]

  • 18. An enzyme immunoassay for determining 17alpha-hydroxyprogesterone in dried blood spots on filter paper using an ultramicroanalytical system.
    González EC, Marrero N, Pérez PL, Frómeta A, Zulueta O, Herrera D, Martínez L, Castells E.
    Clin Chim Acta; 2008 Aug 10; 394(1-2):63-6. PubMed ID: 18442476
    [Abstract] [Full Text] [Related]

  • 19. Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry.
    Janzen N, Peter M, Sander S, Steuerwald U, Terhardt M, Holtkamp U, Sander J.
    J Clin Endocrinol Metab; 2007 Jul 10; 92(7):2581-9. PubMed ID: 17456574
    [Abstract] [Full Text] [Related]

  • 20. Generation of monoclonal antibodies against 17α-hydroxyprogesterone for newborn screening of congenital adrenal hyperplasia.
    Morejón García G, García de la Rosa I, González Reyes EC, Rubio Torres A, Quintana Guerra JM, Hernández Marín M, Pérez Mora PL, Feal Carballo S, Lafita Delfino Y, Pupo Infante M, Castells Martínez EM, Rosabal Poloshkov A, Hernández Pérez L.
    Clin Chim Acta; 2018 Oct 10; 485():311-315. PubMed ID: 30006291
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.